Product serialisation is the assignment of a unique serial number to each saleable unit of a product, so that every individual pack or item can be told apart.12

In the GS1 system, a serial number is assigned to an entity for its lifetime, and when combined with a GTIN it uniquely identifies an individual item.1 The brand owner and the manufacturer are responsible for ensuring serial numbers are not duplicated for a GTIN.1

Serialisation in law

Serialisation is best documented in rules for medicines. Delegated Regulation (EU) 2016/161 requires a unique identifier that is unique to a given pack of a medicinal product.2 The identifier consists of a product code, a serial number of at most 20 characters generated by a deterministic or non-deterministic randomisation algorithm, a national reimbursement number where required, the batch number and the expiry date.2 The regulation’s recitals say randomisation rules are meant to give a negligible probability that falsifiers can guess a serial number.2

In the United States, the Drug Supply Chain Security Act defines a standardized numerical identifier as the National Drug Code for the specific product, including its package configuration, combined with a unique alphanumeric serial number of up to 20 characters.3 A product identifier is a standardized graphic that carries the standardized numerical identifier, lot number and expiration date in both human-readable form and a machine-readable data carrier.3 FDA describes the Act as outlining steps to an interoperable, electronic way to identify and trace certain prescription drugs at the package level.4 See DSCSA Compliance and Pharmaceutical Traceability.

Scope and distinctions

A serial number identifies the individual unit. A batch or lot number, covered at Batch Number, groups units made together, and a GTIN, covered at Global Trade Item Number, names the product type.1

What the sources do not establish

No opened source defines product serialisation as a general term. The legal sources concern medicines and drugs, and the GS1 text is generic, so the page does not claim that serialisation is required in other sectors.123

Footnotes

  1. GS1, “GS1 General Specifications Standard”, release 26.0. https://www.gs1.org/docs/barcodes/GS1_General_Specifications.pdf ↩ ↩2 ↩3 ↩4 ↩5

  2. European Commission, “Commission Delegated Regulation (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules for the safety features appearing on the packaging of medicinal products for human use”, legislation.gov.uk copy. https://www.legislation.gov.uk/eur/2016/161/adopted/data.htm ↩ ↩2 ↩3 ↩4 ↩5

  3. US Congress, Drug Quality and Security Act, Public Law 113-54 (GovInfo text). https://www.govinfo.gov/content/pkg/PLAW-113publ54/html/PLAW-113publ54.htm ↩ ↩2 ↩3

  4. US Food and Drug Administration, “Drug Supply Chain Security Act (DSCSA)”. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa ↩